Ability of Whole-Genome SNP Arrays to Capture ‘Must have‘ Pharmacogenomic Variants

Abstract

Eric J Peters1,2 1UNC Institute for Pharmacogenomics and Individualized Therapy, Division of Pharmacotherapy and Experimental Therapeutics, Division of Hematology and Oncology, and the Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA 2Current address: Illumina, Inc. 9865 Towne Centre Dr, San Diego, CA 92121 Howard L McLeod1† †Author for correspondence: 1UNC Institute for Pharmacogenomics and Individualized Therapy, Division of Pharmacotherapy and Experimental Therapeutics, Division of Hematology and Oncology, and the Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA Tel.: +1 919 966 0512 Fax: +1 919 966 0644 hmcleod@unc.edu Ability of whole-genome SNP arrays to capture ‘must have’ pharmacogenomic variants